Biotherapeutic Agents and Infectious Diseases:
In Biotherapeutic Agents and Infectious Diseases, leading investigators active in the discovery, development, and application of this novel class of anti-infective agents concisely review the use of these special microorganisms in treating human disease. Focusing on biotherapeutic entities that have...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
1999
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | In Biotherapeutic Agents and Infectious Diseases, leading investigators active in the discovery, development, and application of this novel class of anti-infective agents concisely review the use of these special microorganisms in treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic potential, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities. As an alternative to antibiotics that increasingly lead to drug-resistant pathogens, the living microorganisms described in this timely and authoritative book will significantly aid today's clinicians in the prevention and treatment of infectious diseases |
Beschreibung: | 1 Online-Ressource (XII, 316 p) |
ISBN: | 9781592597116 |
DOI: | 10.1007/978-1-59259-711-6 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046147312 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1999 |||| o||u| ||||||eng d | ||
020 | |a 9781592597116 |9 978-1-59259-711-6 | ||
024 | 7 | |a 10.1007/978-1-59259-711-6 |2 doi | |
035 | |a (ZDB-2-SME)978-1-59259-711-6 | ||
035 | |a (OCoLC)1119077387 | ||
035 | |a (DE-599)BVBBV046147312 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.9 |2 23 | |
245 | 1 | 0 | |a Biotherapeutic Agents and Infectious Diseases |c edited by Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz |
264 | 1 | |a Totowa, NJ |b Humana Press |c 1999 | |
300 | |a 1 Online-Ressource (XII, 316 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a In Biotherapeutic Agents and Infectious Diseases, leading investigators active in the discovery, development, and application of this novel class of anti-infective agents concisely review the use of these special microorganisms in treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic potential, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities. As an alternative to antibiotics that increasingly lead to drug-resistant pathogens, the living microorganisms described in this timely and authoritative book will significantly aid today's clinicians in the prevention and treatment of infectious diseases | ||
650 | 4 | |a Infectious Diseases | |
650 | 4 | |a Emerging infectious diseases | |
700 | 1 | |a Elmer, Gary W. |4 edt | |
700 | 1 | |a McFarland, Lynne V. |4 edt | |
700 | 1 | |a Surawicz, Christina M. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475746525 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780896036475 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475746518 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-59259-711-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031527497 | ||
966 | e | |u https://doi.org/10.1007/978-1-59259-711-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180486514278400 |
---|---|
any_adam_object | |
author2 | Elmer, Gary W. McFarland, Lynne V. Surawicz, Christina M. |
author2_role | edt edt edt |
author2_variant | g w e gw gwe l v m lv lvm c m s cm cms |
author_facet | Elmer, Gary W. McFarland, Lynne V. Surawicz, Christina M. |
building | Verbundindex |
bvnumber | BV046147312 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-59259-711-6 (OCoLC)1119077387 (DE-599)BVBBV046147312 |
dewey-full | 616.9 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.9 |
dewey-search | 616.9 |
dewey-sort | 3616.9 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-59259-711-6 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02750nmm a2200433zc 4500</leader><controlfield tag="001">BV046147312</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1999 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781592597116</subfield><subfield code="9">978-1-59259-711-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-59259-711-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-59259-711-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119077387</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147312</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biotherapeutic Agents and Infectious Diseases</subfield><subfield code="c">edited by Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 316 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In Biotherapeutic Agents and Infectious Diseases, leading investigators active in the discovery, development, and application of this novel class of anti-infective agents concisely review the use of these special microorganisms in treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic potential, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities. As an alternative to antibiotics that increasingly lead to drug-resistant pathogens, the living microorganisms described in this timely and authoritative book will significantly aid today's clinicians in the prevention and treatment of infectious diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Emerging infectious diseases</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Elmer, Gary W.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McFarland, Lynne V.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Surawicz, Christina M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475746525</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780896036475</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475746518</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-59259-711-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527497</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-59259-711-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046147312 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:32Z |
institution | BVB |
isbn | 9781592597116 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527497 |
oclc_num | 1119077387 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XII, 316 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1999 |
publishDateSearch | 1999 |
publishDateSort | 1999 |
publisher | Humana Press |
record_format | marc |
spelling | Biotherapeutic Agents and Infectious Diseases edited by Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz Totowa, NJ Humana Press 1999 1 Online-Ressource (XII, 316 p) txt rdacontent c rdamedia cr rdacarrier In Biotherapeutic Agents and Infectious Diseases, leading investigators active in the discovery, development, and application of this novel class of anti-infective agents concisely review the use of these special microorganisms in treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic potential, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities. As an alternative to antibiotics that increasingly lead to drug-resistant pathogens, the living microorganisms described in this timely and authoritative book will significantly aid today's clinicians in the prevention and treatment of infectious diseases Infectious Diseases Emerging infectious diseases Elmer, Gary W. edt McFarland, Lynne V. edt Surawicz, Christina M. edt Erscheint auch als Druck-Ausgabe 9781475746525 Erscheint auch als Druck-Ausgabe 9780896036475 Erscheint auch als Druck-Ausgabe 9781475746518 https://doi.org/10.1007/978-1-59259-711-6 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Biotherapeutic Agents and Infectious Diseases Infectious Diseases Emerging infectious diseases |
title | Biotherapeutic Agents and Infectious Diseases |
title_auth | Biotherapeutic Agents and Infectious Diseases |
title_exact_search | Biotherapeutic Agents and Infectious Diseases |
title_full | Biotherapeutic Agents and Infectious Diseases edited by Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz |
title_fullStr | Biotherapeutic Agents and Infectious Diseases edited by Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz |
title_full_unstemmed | Biotherapeutic Agents and Infectious Diseases edited by Gary W. Elmer, Lynne V. McFarland, Christina M. Surawicz |
title_short | Biotherapeutic Agents and Infectious Diseases |
title_sort | biotherapeutic agents and infectious diseases |
topic | Infectious Diseases Emerging infectious diseases |
topic_facet | Infectious Diseases Emerging infectious diseases |
url | https://doi.org/10.1007/978-1-59259-711-6 |
work_keys_str_mv | AT elmergaryw biotherapeuticagentsandinfectiousdiseases AT mcfarlandlynnev biotherapeuticagentsandinfectiousdiseases AT surawiczchristinam biotherapeuticagentsandinfectiousdiseases |